Ramifications of screening for breast cancer: Consent for screening [4]

British Medical Journal

Volumn 332, Issue 7543, 2006, Pages 728-

  Baum, Michael ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CLINICAL TRIAL; FOLLOW UP; HEALTH PROGRAM; HUMAN; INFORMED CONSENT; LETTER; MAMMOGRAPHY; MEDICAL LITERATURE; MEDICAL SOCIETY; MEDICAL SPECIALIST; PRIORITY JOURNAL; RADIOLOGY DEPARTMENT; SCREENING; SURGEON; BREAST TUMOR; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ERROR; FEMALE; MASS SCREENING; NOTE; RANDOMIZED CONTROLLED TRIAL; STANDARD; SWEDEN;

BREAST NEOPLASMS; DIAGNOSTIC ERRORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFORMED CONSENT; MAMMOGRAPHY; MASS SCREENING; RANDOMIZED CONTROLLED TRIALS; SWEDEN;

EID: 33645522311     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Baum M. Screening for breast cancer, time to think-and stop? Lancet 1995;346:436-7.
2. Jørgensen KJ, Gøtzsche PC, Content of invitations for publicly funded screening mammography. BMJ 2006;332:538-41. (4 March.)
3. Zackrisson S, Andersson I, Janzon L, Manjer J, Garne JP. Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study. BMJ 2006;332:689-92. (25 March,) doi:10.1136/bmj.38764.572569.7C (published 3 March 2006).